The Latest Breaking News from NYSE

Over the past 3 months, 6 analysts have published their opinion on DoubleVerify Hldgs (NYSE:DV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Within the last quarter, CF Industries Holdings (NYSE:CF) has observed the following analyst ratings:

Palantir Technologies Inc (NYSE: PLTR) shares are trading lower by 13.61% at $8.19 after the company said it expects second-quarter revenue below analyst estimates.

Rivian Automotive Inc (NASDAQ: RIVN) shares are trading lower Monday morning following a report that Ford Motor Co (NYSE: F) is selling 8 million shares of the electric vehicle company. 

Myovant Sciences Ltd (NYSE:MYOV) and Accord Healthcare Ltd have entered into an exclusive license agreement to commercialize Orgovyx (relugolix) for advanced hormone-sensitive prostate cancer in the European Economic Area, the U.K., Switzerland, and Turkey. Accord has the right to the first negotiation if Myovant decides to enter into licensing arrangements in countries in the Middle…

  Clarivate (NYSE:CLVT) reported its Q1 earnings results on Monday, May 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

  GCP Applied Technologies (NYSE:GCP) reported its Q1 earnings results on Monday, May 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading.

Party City Holdco Inc (NYSE:PRTY) reported first-quarter FY22 sales growth of 1.4% year-on-year to $432.98 million, missing the consensus of $435.80 million. Brand comparable sales increased 2.1% versus last year. Total retail sales increased 2.3%. The gross profit margin decreased 380 basis points Y/Y to 31.9%. The operating loss for the quarter was…

Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ: IBB), considered a proxy for the sector, shed close to 3 percent during the week.

CNBC Ford Motor Selling 8M Shares Of Rivian Automotive